drugset
drugset / Trial / NCT05136053

A Study Investigating Lu AG22515 in Healthy Adults

NCT05136053 ↗

Phase 1 Completed 58 enrolled H. Lundbeck A/S
RandomizedSequentialDouble-blindBasic science

Summary

The main goal of this study is to learn more about the safety of a drug called Lu AG22515. During the trial, healthy adult participants will receive a single dose of Lu AG22515 or a placebo (normal saline solution).

Timeline

Start
2022-03-18
Primary completion
2023-08-05
Completion
2023-08-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AG22515 Unknown — Intravenous

Indications

No indication recorded.